Search clinical trials for: oritavancin

Total 19 results

Targanta Therapeutics Corporation

Completed

A Study for Patients With Complicated Skin and Skin Structure Infections (SIMPLIFI)

Wounds and Injuries | Streptococcal Infections | Abscess | Cellulitis | Staphylococcal Skin Infections

United States, Australia, India, Italy, Romania, Ukraine
Melinta Therapeutics, Inc.

Completed

Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers (DDI)

Healthy

United States
Melinta Therapeutics, Inc.

Completed

Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects

Healthy

United States
University of Pennsylvania

Withdrawn

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Staphylococcus Aureus Bacteremia | Staphylococcus Aureus Endocarditis

United States
Melinta Therapeutics, Inc.

Completed

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Acute Bacterial Skin and Skin Structure Infection

United States
Melinta Therapeutics, Inc.

Completed

A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants

Healthy

United States
The Medicines Company

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers

Healthy

United States
Melinta Therapeutics, LLC

Recruiting

Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous (IV) Oritavancin

Acute Bacterial Skin and Skin Structure Infection

United States, Spain, Greece, Portugal, Bulgaria, Latvia, Romania, Lithuania, Poland
Melinta Therapeutics, LLC

Recruiting

Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections

Gram Positive Bacterial Infections

United States
Melinta Therapeutics, Inc.
Christchurch Clinical Studies Trust Ltd

Completed

Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers

Healthy Volunteers

New Zealand
Melinta Therapeutics, Inc.

Completed

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

Gram-Positive Bacterial Infections

United States
Melinta Therapeutics, Inc.

Completed

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection (SOLO II)

Abscess | Cellulitis | Wound Infection | Systemic Inflammation

United States
The Medicines Company

Completed

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Acute Bacterial Skin and Skin Structure Infection

United States
Melinta Therapeutics, Inc.

Completed

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) (SOLO I)

Abscess | Cellulitis | Wound Infection | Systemic Inflammation

United States
The Medicines Company

Completed

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Skin Diseases, Bacterial

United States
Melinta Therapeutics, Inc.

Completed

Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects

Healthy

United States
University of Maryland, Baltimore

Not yet recruiting

Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use (AIM-STOP)

Bacteremia | Substance Use Disorders | Septic Arthritis | Infection, Soft Tissue | Osteomyelitis Acute
Endo Pharmaceuticals

Terminated

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Carcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder Cancer

United States
West Virginia University

Enrolling by invitation

Comparing Oral Versus Parenteral Antimicrobial Therapy (COPAT)

Skin and Soft Tissue Infection | Gastrointestinal Infection | Pulmonary Infection | Bone and Joint Infection | Endovascular Infection | Genitourinary Infection

United States

3

Subscribe